Enalapril is better suited for patients with all degrees of hypertension, especially for the treatment of patients with renal vascular hypertension and hypertensive disorders combined with diabetes mellitus, and is often used in combination with diuretics such as hydrochlorothiazide.
Enalapril belongs to the angiotensin converting enzyme inhibitor (ACEI) class of drugs. After oral administration, it is hydrolyzed in the body into enalapril, which inhibits angiotensin-converting enzyme, thus reducing the production of angiotensin II and decreasing vasodilatory blood pressure. Enalapril and captopril are the same ACEI drug, but the effect is better than captopril.
Adverse drug reactions may include dizziness, headache, drowsiness, fatigue, epigastric discomfort, nausea, slow heartbeat, chest tightness, cough and proteinuria rash. The dosage needs to be reduced if necessary, and the drug needs to be discontinued if there is leukopenia. It is contraindicated in people who are allergic to enalapril or in patients with bilateral renal artery stenosis. It should be used with caution in children, pregnant women, lactating women, and people with severely impaired renal function.
It is recommended that patients with hypertension take Enalapril as prescribed by the doctor after visiting the hospital.